Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JCLB | ISIN: FR0011049824 | Ticker-Symbol: 4ZG
Frankfurt
25.04.24
08:18 Uhr
3,260 Euro
0,000
0,00 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDIAN TECHNOLOGIES Chart 1 Jahr
5-Tage-Chart
MEDIAN TECHNOLOGIES 5-Tage-Chart
RealtimeGeldBriefZeit
3,2153,52508:04

Aktuelle News zur MEDIAN TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoMedian Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information146Q1 2024 revenue at €5.4 million as of March 31, 2024, with growth expected for the remainder of 2024. Order backlog as of March 31, 2024: €68.2 million, an increase in backlog as of December...
► Artikel lesen
10.04.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31st, 2024217Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
08.03.Median Technologies: Disclosure of total number of voting rights and number of shares in the capital as of February 29th, 2024344Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
29.02.Median Technologies to Participate in the TD Cowen's 44th Annual Health Care Conference276Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) (Paris:ALMDT), will be participating in the TD Cowen's 44th Annual Health Care Conference, taking place on March 4 6...
► Artikel lesen
26.02.Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 - March 3, Vienna, Austria241Two presentations at the AI Theater Industry Sessions/AI Lightning Talks, Scientific poster: "Developing a novel computer-aided diagnostic technique based on deep learning and CT images...
► Artikel lesen
08.02.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31st, 2024405Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
29.01.Median Technologies Reports 2023 Revenue and Summarizes 2024 Strategic Outlook462iCRO order backlog: €66.9m, an all-time high for Median, driven by record order intake in Q4 2023. 2023 revenue: €22.2m, below 2022 revenue. Independent verification study for eyonis...
► Artikel lesen
26.01.New Date for Median Technologies' Webcasts: February 1st, 2024474Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announced today that Fredrik Brag, CEO and Founder of Median Technologies, will provide a company update on February...
► Artikel lesen
25.01.Median Technologies to Host Two Webcasts, and Provide a Company Update on January 30, 2024366Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) (Paris:ALMDT) announced today that Fredrik Brag, CEO and Founder of Median Technologies, will provide a company update...
► Artikel lesen
22.01.Median Technologies: Financial Communications Schedule for the First Half of 2024275Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible), announces the publication date for its 2023 results: Publication Date 2023 results April...
► Artikel lesen
17.01.Median Technologies' new AI algorithm boosts lung cancer detection1
17.01.Median Technologies Reports Excellent Results from Its Independent Verification Study376In an important milestone towards market introduction, Median Technologies announces that its CADe/CADx Software as Medical Device (SaMD), eyonis LCS, has demonstrated excellent performance in an...
► Artikel lesen
10.01.Median Technologies: Half Year Liquidity Contract Statement275Regulatory News: Under the liquidity contract entrusted by Median Technologies (FR0011049824 ALMDT FP) to TP ICAP (Europe), the following resources were listed in the liquidity account as of 12/29/2023:...
► Artikel lesen
08.01.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31st, 2023354Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
27.12.23Median Technologies Announces the Drawdown of €8.5m Corresponding to the Final Tranche of the European Investment Bank Loan403Regulatory News: Median Technologies (Paris:ALMDT) announces that it has received approval from the European Investment Bank to draw down the final tranche of the loan granted on December 18, 2019...
► Artikel lesen
14.12.23Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine286The association aims to develop and implement smart imaging biomarkers to better understand the mechanism of action (MOA) of oncology drugs and collect more evidence of efficiency in early phase...
► Artikel lesen
07.12.23Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30th, 2023344Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
30.11.23Median Technologies to Speak at the IASLC 2023 North America Conference on Lung Cancer (NACLC), Dec. 1-3, Chicago, IL, USA, with two Presentations358eyonis (formerly known as iBiopsy®) scientific poster presentation: End-to-End AI model for Nodule Detection and Characterization in Lung Cancer Screening: Performances and Subpopulation Analysis...
► Artikel lesen
27.11.23Median Technologies Selected for Support Under the French Government's ETIncelles Program289Median Technologies is among the first 50 companies to be chosen to join the French government's ETIncelles program. The ETIncelles program aims to transform 500 French high growth potential...
► Artikel lesen
26.11.23Median Technologies Announces Rebranding of iBiopsy, Changes Name to eyonis500The Company announces a new identity for its iBiopsy® AI/ML tech-based suite of software as medical devices (SaMD), and business unit. iBiopsy® becomes eyonis. eyonis brand visual...
► Artikel lesen
Seite:  Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1